McNeely, Hare & War LLP
12 Roszel Road, Suite C104
Princeton, NJ 08540
Phone: 609 731 3668
Fax: 202 478 1813
chris@miplaw.com

Christopher S. Casieri is a partner in the Princeton, New Jersey office of McNeely, Hare & War LLP.  He has over 11 years of patent law practice in the areas of litigation, opinions and prosecution. Chris has represented a variety of clients from small start-up companies to large multinational corporations.

Chris’ opinion and counseling practice includes the areas of infringement, validity, freedom to operate and API clearance advice. He is experienced in evaluating and responding to infringement allegations, as well as providing design-around advice and risk analysis.

In the prosecution of patents, Chris handles preparation, prosecution and appeals of domestic patents and oversees the prosecution and opposition of international patents. He also drafts and negotiates license, purchase and settlement agreements and various contracts.

Chris’ experience covers a wide range of industries, including natural products, pharmaceuticals, industrial chemicals, mechanical devices and instrumentation. Chris has bachelor and master degrees in chemistry. Prior to law school, Chris worked for 5 years as a pharmaceutical chemist.

Litigation Experience

Pfizer Inc. and UCB Pharma GMBH v. Amerigen Pharmaceuticals, Inc. and Amerigen Pharmaceuticals Ltd., 13-cv-1156 (D. Del).  Representing Amerigen in the defense of a patent infringement case for the filing of a NCE-1, FTF ANDA case for the pharmaceutical product, Toviaz® (fesoterodine).

Astrazeneca AB, Aktiebolaget Hassle, Astrazeneca LP, KBI, Inc. and KBI-E Inc. v. Wockhardt Limited and Wockhardt USA LLC, 13-cv-04854 (D. NJ).  Representing Wockhardt in the defense of a patent infringement case of the filing of an ANDA case for the pharmaceutical product, Nexium® (esomeprazole).

Chico’s FAS, Inc. v. 1654754 Ontario, Inc. d/b/a Wink Intimates, 13-cv-00792 (M.D. FL).  Representing Wink Intimates and its owners in the defense of a Declaratory Judgment action asserting noninfringement and invalidity of utility and design patents covering a tank top-camisole product.

Forest Laboratories, Inc. and Forest Laboratories Holdings, Ltd. v. Amerigen Pharmaceuticals Inc. and Amerigen Pharmaceuticals Ltd., 12-cv-5026 (E.D. Ill).  Represented Amerigen in the defense of a patent infringement case for the filing of a NCE-1, FTF ANDA case for the pharmaceutical product, Bystolic® (nebivolol).  Obtained settlement and dismissal of case.